Lineage Cell Therapeutics Inc LCTXAMEX
1.13USDClose on 08/10
At a glance
Lineage Cell Therapeutics Inc sits in the ‘Resting’ stage of its cycle. It has moved -27.1% since its first surge signal on 2025-09-18, when the past-year gain stood at +66.7%.
- Since surge signal
- -27.1%
- First surge signal
- 2025-09-18
- Price at signal
- 1.55
- Past-year gain (at signal)
- +66.7%
- Sector
- Biotech
- Market
- US
- As of
- 2026-08-10
Start the AI analysis
No analysis has been run for this ticker today. It takes about a minute.